A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP)

A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP)

Abstract Cefepime and piperacillin/tazobactam are antimicrobials recommended by IDSA/ATS guidelines for the empirical management of patients admitted to the intensive care unit (ICU) with community-acquired pneumonia (CAP). Concerns have been raised about which should be used in clinical practice. T...

Full description

Bibliographic Details
Main Authors: Cristian C. Serrano-Mayorga, Sara Duque, Elsa D. Ibáñez-Prada, Esteban Garcia-Gallo, María P. Rojas Arrieta, Alirio Bastidas, Alejandro Rodríguez, Ignacio Martin-Loeches, Luis F. Reyes
Format: Article
Language:English
Published: Nature Portfolio 2024-06-01
Series:Scientific Reports
Subjects:
Community-acquired pneumonia (CAP)
Intensive care unit (ICU)
Cefepime
Piperacillin/tazobactam
Targeted maximum likelihood estimation (TMLE)
Online Access:https://doi.org/10.1038/s41598-024-64444-3

Internet

https://doi.org/10.1038/s41598-024-64444-3

Similar Items